On the 28th May 2024, European Commission approves Holostem project on cell and gene therapy as one of the Important Project of Common European Interest in the health sector (IPCEI Med4Cure). For details please follow the link.
On 22 February 2024, the European Commission ratified, with decision no. 1299 (2024) the passage of the European marketing authorization for Holoclar, cell therapy for the orphan designation of Limbal Stem Cell Deficiency, from ”conditional” to FULL . Holoclar is…
June 24, 2022 - A life-changing treatment to reverse injury-related sight loss is now available to patients at specialist centres across England, thanks to a partnership between Newcastle Hospitals and Italian medicines manufacturer, Holostem. The specialist advanced therapy, known as…
The board of directors unanimously approved the company's evolution into a nonprofit organization Holostem will remain an international point of reference for patients and research Modena, 1st of June 2022 – The Board of Directors of Holostem Terapie Avanzate, which…
Epidermolysis bullosa (EB), better known as butterfly baby disease, is a genetic disorder that involves the continuous formation of bullous lesions on the skin, due to very small mechanical trauma and minimal rubbing, which strongly impact the quality of life…
Modena, September 27th, 2021 - On October 1st, Holostem Terapie Avanzate and the Centre for Regenerative Medicine "Stefano Ferrari" at the University of Modena and Reggio Emilia - in collaboration with the "Le Ali di Camilla" Association - will organise a…
On Thursday 3 June, the second event dedicated to the exploration of the assets identified during 2020 in the in-depth analysis of the potential and prospective attractiveness carried out on the health and wellness sector in Emilia-Romagna will be held.…
Modena, Italy / Brno, Czech Republic, May 12, 2021 - Holoclar®, the first stem cell-based medicinal product approved and formally registered in the Western world in 2015, is now available also in Czech Republic. Holoclar®, manufactured and distributed by Holostem…
Modena, 23 April 2021 - The European Research Council (ERC) yesterday announced the winners of the 2020 Advanced Grants. The grants, worth a total of €507 million, will support 209 researchers across Europe. Eight projects were won by researchers working…
Modena, Italy, January 14th, 2021 - “Italy on the move”, a new Life science companies networking opportunity, is at the third year edition. The event was at the first time on a digital platform, and happened in the same days…
